MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$1,407K
Free Cash flow
$11,411K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Accrued retrospective premiums
Proceeds from sales of short-ter...
Stock-based compensation
Others
Negative Cash Flow Breakdown
Purchases of short-term investme...
Net loss
Healthcare receivables
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2025-09-30
2025-06-30
Net loss
-24,377
-11,852
Depreciation and amortization expense
406
860
Stock-based compensation
26,106
52,632
Change in fair value of warrants and amortization of warrants
0
19
Accretion, net of amortization
-396
-946
Change in accrued interest earned
-379
-347
Net realized gains on investment securities
188
437
Loss on investment
0
0
Accrued retrospective premiums
38,884
-43,201
Prepaid expenses
-2,785
2,078
Other assets
8,367
2,084
Healthcare receivables
11,048
-4,646
Unpaid claims
797
-16,736
Accounts payable and accrued expenses
-1,013
-613
Accrued salaries and benefits
-8,013
6,094
Other liabilities
-3,852
2,464
Net cash provided by operating activities from continuing operations
12,103
-10,885
Net cash used in operating activities from discontinued operations
0
0
Net cash provided by operating activities
12,103
-10,885
Purchases of short-term investments, available-for-sale, and held-to-maturity securities
39,127
59,864
Proceeds from sales of short-term investments and available-for-sale securities
34,394
79,313
Proceeds from maturities of short-term investments and available-for-sale securities
0
25,801
Purchases of property and equipment
692
754
Net cash provided by investing activities
-5,425
44,496
Issuance of common stock, net of early exercise liability
305
363
Issuance of common stock under employee stock purchase plan, net of stock issuance costs
0
555
Cash paid for shares withheld related to stock-based compensation
5,575
22,127
Repurchases of common stock
1
18,297
Net cash used in financing activities
-5,271
-39,506
Net (decrease) increase in cash and cash equivalents
1,407
-5,895
Cash and cash equivalents at beginning of period
194,543
-
Cash and cash equivalents at end of period
190,055
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Accrued retrospective
premiums
$38,884K
Stock-based compensation
$26,106K
Prepaid expenses
-$2,785K
Unpaid claims
$797K
Depreciation and
amortization expense
$406K
Change in accrued
interest earned
-$379K
Net cash provided by
operating activities from...
$12,103K
Canceled cashflow
$57,254K
Net cash provided by
operating activities
$12,103K
Net loss
-$24,377K
Healthcare receivables
$11,048K
Other assets
$8,367K
Accrued salaries and
benefits
-$8,013K
Other liabilities
-$3,852K
Accounts payable and
accrued expenses
-$1,013K
Accretion, net of
amortization
-$396K
Net realized gains
on investment...
$188K
Net (decrease)
increase in cash and cash...
$1,407K
Canceled cashflow
$10,696K
Proceeds from sales of
short-term investments and...
$34,394K
Issuance of common stock,
net of early...
$305K
Net cash provided by
investing activities
-$5,425K
Net cash used in
financing activities
-$5,271K
Canceled cashflow
$34,394K
Canceled cashflow
$305K
Purchases of short-term
investments,...
$39,127K
Cash paid for shares
withheld related to...
$5,575K
Purchases of property and
equipment
$692K
Repurchases of common stock
$1K
Buy us a coffee
CLOVER HEALTH INVESTMENTS, CORP. DE (CLOV)
CLOVER HEALTH INVESTMENTS, CORP. DE (CLOV)